Condition: Ulcerative Colitis (UC) · Sponsor: AbbVie
This is a registry study to evaluate the long-term safety and effectiveness of adalimumab in patients with moderately to severely active UC who are treated as recommended in the product label.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Birmingham Gastroenterology Associates P.C /ID# 102063 | Birmingham, Alabama, United States | — |
| University of Alabama at Birmingham - Main /ID# 131646 | Birmingham, Alabama, United States | — |
| Longwood Research /ID# 118662 | Huntsville, Alabama, United States | — |
| East View Medical Research, LLC /ID# 116259 | Mobile, Alabama, United States | — |
| Mobile Medical & Diagnostic Center, AL /ID# 102064 | Mobile, Alabama, United States | — |
| HOPE Research Institute /ID# 127947 | Phoenix, Arizona, United States | — |
| Duplicate_University of Arizona Cancer Center - North Campus /ID# 140387 | Tucson, Arizona, United States | — |
| University Of Arizona /ID# 117836 | Tucson, Arizona, United States | — |
| Arkansas Gastroenterology /ID# 113898 | North Little Rock, Arkansas, United States | — |
| Southern California Res. Ctr. /ID# 116898 | Coronado, California, United States | — |
| Moores Cancer Center at UC San Diego /ID# 133722 | La Jolla, California, United States | — |
| McGuire, Jr. La Mirada, CA /ID# 116257 | La Mirada, California, United States | — |
+ 500 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.